Suppression of Bcl-2 has been shown to inhibit tumor growth in several mouse xenograft models including H146 and H1963 (small cell lung cancer), and SKOV3; increase sensitivity to anticancer drugs; and enhance survival (43, 44). This evidence concerns the gene BCL2 and neoplasm.